LETM1 contributes to cancer cell proliferation and invasion via the PI3K/Akt signaling pathway and has been identified as a potential biomarker to predict the prognosis of gastric cancer and lung cancer (Piao et al., 2019; Li et al., 2020; Zhang et al., 2020). This evidence concerns the gene LETM1 and gastric cancer.